What is the most appropriate next step in evaluating a 28‑year‑old woman with irregular menstrual cycles since delivering a child 2.5 years ago, 25 kg weight gain, mild facial hirsutism, normal free and total testosterone, low dehydroepiandrosterone sulfate (DHEAS), and normal thyroid‑stimulating hormone (TSH)?

Evaluate for PCOS and Consider Functional Hypothalamic Amenorrhea

The most appropriate next step is to obtain a pelvic ultrasound to assess for polycystic ovary morphology and measure serum prolactin, followed by evaluation for metabolic complications of PCOS including fasting glucose/insulin and lipid panel. 1

Clinical Reasoning

This 28-year-old woman presents with a classic constellation suggesting polycystic ovary syndrome (PCOS): irregular menses since postpartum (2.5 years of oligomenorrhea), significant weight gain (25 kg), and mild hirsutism. The normal testosterone levels do not exclude PCOS—in fact, even normal degrees of focal hirsutism are usually associated with hyperandrogenemia when menstrual irregularity is present 1, though some women with PCOS may have normal androgen levels.

The low DHEAS is notable but does not exclude PCOS. While DHEAS measurement is recommended to exclude adrenal hyperandrogenism 1, low levels can occur in PCOS, particularly in overweight women where adrenal androgens tend to be lower 2. This finding should not distract from the primary diagnosis.

Algorithmic Workup

Immediate Next Steps:

1. Pelvic ultrasonography - Essential to detect polycystic ovary morphology (≥12 follicles of 2-9 mm or ovarian volume >10 mL) or exclude an ovarian neoplasm 1

2. Serum prolactin - Required to exclude hyperprolactinemia, which can present with amenorrhea and hirsutism 1

3. Early morning 17-hydroxyprogesterone - While less likely given normal testosterone, this excludes nonclassic congenital adrenal hyperplasia 1

Metabolic Screening (Critical for Long-term Outcomes):

Given the 25 kg weight gain and high likelihood of PCOS, immediate metabolic assessment is essential 1, 3:

• Fasting glucose and insulin (or oral glucose tolerance test)
• Complete lipid profile (HDL cholesterol and triglycerides)
• Screen for acanthosis nigricans on physical exam

The metabolic complications—insulin resistance, dyslipidemia, and cardiovascular risk—represent the most significant threats to morbidity and mortality in PCOS patients 3. These risks warrant aggressive screening even before confirming the diagnosis.

Diagnostic Criteria for PCOS

If the evaluation excludes other disorders, PCOS diagnosis requires 2 of 3 Rotterdam criteria 4:

• Hyperandrogenism (clinical hirsutism counts, even with normal labs)
• Ovulatory dysfunction (her 2.5 years of irregular menses qualifies)
• Polycystic ovary morphology on ultrasound

This patient likely already meets 2 criteria clinically (oligomenorrhea + hirsutism), making PCOS highly probable.

Alternative Consideration: Functional Hypothalamic Amenorrhea

The postpartum timing and low DHEAS raise a secondary consideration of functional hypothalamic amenorrhea (FHA), particularly if significant stressors, excessive exercise, or eating disorders are present 2. However, the 25 kg weight gain (not loss) and hirsutism make this less likely. In FHA, you would expect:

• Low-normal gonadotropins (LH <10, FSH <10)
• Low-normal testosterone
• Normal or low DHEAS
• Absence of hirsutism and weight gain

If gonadotropins are measured and found to be low, consider FHA as an overlay diagnosis, though the metabolic profile still demands PCOS evaluation.

Critical Pitfalls to Avoid

• Do not dismiss PCOS based on normal testosterone alone 1—clinical hyperandrogenism (hirsutism) with anovulation is sufficient
• Do not delay metabolic screening—the cardiovascular and diabetes risks are the primary threats to this patient's long-term health 3
• Do not overlook the postpartum context—while lactational amenorrhea is normal, 2.5 years of irregular menses with weight gain and hirsutism is pathologic
• Do not attribute everything to postpartum changes—this presentation demands endocrine evaluation

Treatment Implications

Once PCOS is confirmed and metabolic complications assessed, treatment priorities include 3:

• Weight reduction (even 7% weight loss can restore ovulation and improve hirsutism)
• Oral contraceptives for menstrual regulation and hirsutism (if not desiring pregnancy)
• Metformin if insulin resistance is documented
• Antiandrogens (spironolactone) can be added after 6 months if hirsutism persists

The goal is not just symptom management but prevention of type 2 diabetes, cardiovascular disease, and endometrial cancer—the true determinants of morbidity and mortality in PCOS 3.